The blood-based test takes advantage of proprietary technology that makes it very sensitive to even low levels of the protein, which could make it a useful tool for screening for the disease.

The US Food and Drug Administration has given marketing clearance to a blood test to help diagnose Alzheimer’s disease, making the test the first to get signoff to aid in the early detection of ...

The Food and Drug Administration has authorized the use of Labcorp's blood-based in-vitro diagnostic test that's works by detesting the amyloid plaques associated with the disease in certain patients.

The U.S. Food and Drug Administration on Friday approved a new blood test for the early detection of Alzheimer's disease in patients beginning to show cognitive decline.

The US Food and Drug Administration has approved a blood test to be used for colorectal cancer screening among average-risk adults 45 and older.

A new generation of blood tests can help diagnose Alzheimer’s disease. But many doctors don’t yet know how to use them.

In patients showing cognitive decline, a new blood test for Alzheimer's is expected to make diagnosis more convenient, accessible and inexpensive than other existing tests.

Multiple myeloma’s ability to foster innovation drives comparatively lofty drug sales for its rarity. Evaluate’s internal ...

Medical technologists in drug testing and blood banking play a crucial role in public health by ensuring the integrity and accuracy of drug tests and blood supplies. Their responsibilities span ...

While the new Shield blood test may motivate more people to get screened for colorectal cancer, it also comes with downsides, experts said.